GlassScriptPhysician profile
Kari N Holly
NPI 1588102594
$2,174.43
in general payments reported to CMS, 2019-2025
12 companies · $805 in 2025
The $805 reported for 2025 was more than what 82% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $232 · 2022: $211 · 2023: $555 · 2024: $371 · 2025: $805.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,731.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,730.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $848.72 | 2022-2025 | Grafix Pl, Oasis, Grafix |
| Organogenesis INC. | $346.47 | 2021-2024 | Apligraf, Puraply |
| Next Science LLC | $238.41 | 2023 | Blastx, Xperience, Surgx |
| Mimedx Group, INC. | $193.45 | 2024-2025 | |
| Silk Road Medical, INC. | $145.84 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Abbott Laboratories | $104.99 | 2023 | Freestyle Libre 3 |
| Hydrofera LLC | $72.27 | 2022-2024 | Hydrofera Blue |
| Cashflow Solutions, LLC | $55.64 | 2025 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Kci USA, INC. | $53.35 | 2021 | |
| Solventum Corporation | $47.45 | 2024-2025 | Kerramax Care, Activ.A.C., Promogran Prisma |
| Hartmann USA, INC. | $43.25 | 2025 | Zetuvit Plus 10x10 P10 |
| Integra Lifesciences Corporation | $24.59 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kari Holly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.